Roberto Visentin

According to our database, Roberto Visentin authored at least 15 papers between 2015 and 2024.

Collaborative distances:

• Dijkstra number of five.
• Erdős number of four.

2024

Tailoring the Padova Type 2 Diabetes Simulator for Treatment Guidance in Target Populations.

Roberto Visentin, Michele Schiavon, Jacopo Bonet, Michela Riz, Britta Wagenhuber, Chiara Dalla Man

IEEE Trans. Biomed. Eng., June, 2024

Modeling Doxorubicin Pharmacokinetics in Multiple Myeloma Suggests Mechanism of Drug Resistance.

Roya Doshmanziari, Francesco Da Ros, Mario Mazzucato, Morten Gram Pedersen, Roberto Visentin

IEEE Trans. Biomed. Eng., March, 2024

2022

A software interface for <i>in silico</i> testing of type 2 diabetes treatments.

Roberto Visentin, Claudio Cobelli, Chiara Dalla Man

Comput. Methods Programs Biomed., 2022

Glucose Controlin Type 2 Diabetes: In Silico Study of Sub-Optimal Adherence to Insulin Therapy.

Roberto Visentin, Claudio Cobelli, Jochen Sieber, Chiara Dalla Man

Proceedings of the 10th International Conference on Systems and Control, 2022

2021

A Novel Method for Generation of In Silico Subjects with Type 2 Diabetes.

Roberto Visentin, Mattia De Lazzari

Proceedings of the 43rd Annual International Conference of the IEEE Engineering in Medicine & Biology Society, 2021

Modeling Pharmacokinetics of Doxorubicin in Multiple Myeloma Cells.

Alberto Giaretta, Francesco Da Ros, Mario Mazzucato, Morten Gram Pedersen, Roberto Visentin

Proceedings of the 43rd Annual International Conference of the IEEE Engineering in Medicine & Biology Society, 2021

2020

Modeling Subcutaneous Absorption of Long-Acting Insulin Glargine in Type 1 Diabetes.

Michele Schiavon, Roberto Visentin, Clemens Giegerich, Thomas Klabunde, Claudio Cobelli, Chiara Dalla Man

IEEE Trans. Biomed. Eng., 2020

In Silico Cloning of Target Type 2 Diabetes Population for Treatments Development and Decision Support^*.

Roberto Visentin, Michele Schiavon, Chiara Dalla Man

Proceedings of the 42nd Annual International Conference of the IEEE Engineering in Medicine & Biology Society, 2020

2019

Incorporating Long-Acting Insulin Glargine Into the UVA/Padova Type 1 Diabetes Simulator for In Silico Testing of MDI Therapies.

Roberto Visentin, Michele Schiavon, Clemens Giegerich, Thomas Klabunde, Chiara Dalla Man, Claudio Cobelli

IEEE Trans. Biomed. Eng., 2019

2018

Toward a Run-to-Run Adaptive Artificial Pancreas: In Silico Results.

Chiara Toffanin, Roberto Visentin, Mirko Messori, Federico Di Palma, Lalo Magni, Claudio Cobelli

IEEE Trans. Biomed. Eng., 2018

Long-acting Insulin in Diabetes Therapy: In Silico Clinical Trials with the UVA/Padova Type 1 Diabetes Simulator^*.

Roberto Visentin, Michele Schiavon, Clemens Giegerich, Thomas Klabunde, Chiara Dalla Man, Claudio Cobelli

Proceedings of the 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 2018

A Model of Acetaminophen Pharmacokinetics and its Effect on Continuous Glucose Monitoring Sensor Measurements.

Michele Schiavon, Giada Acciaroli, Martina Vettoretti, Alberto Giaretta, Roberto Visentin

Proceedings of the 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 2018

2017

A Hybrid Clustering Prediction for Type 1 Diabetes Aid: Towards Decision Support Systems Based upon Scenario Profile Analysis.

Iván Contreras, Josep Vehí, Roberto Visentin, Martina Vettoretti

Proceedings of the Second IEEE/ACM International Conference on Connected Health: Applications, 2017

2016

One-Day Bayesian Cloning of Type 1 Diabetes Subjects: Toward a Single-Day UVA/Padova Type 1 Diabetes Simulator.

Roberto Visentin, Chiara Dalla Man, Claudio Cobelli

IEEE Trans. Biomed. Eng., 2016

2015

Incorporation of inhaled insulin into the FDA accepted University of Virginia/Padova Type 1 Diabetes Simulator.

Roberto Visentin, Thomas Klabunde, Marshall Grant, Chiara Dalla Man, Claudio Cobelli

Proceedings of the 37th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 2015